Studies of the interaction of carbenoxolone sodium and warfarin sodiun in vivo [proceedings]

Br J Pharmacol. 1977 June; 60(2): 280P–281P.

PMCID: PMC1667430

S Gottfried, D V Parke, P J Sacra, and P C Thornton

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (322K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

280P

281P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Aggeler, PM; O'Reilly, RA; Leong, L; Kowitz, PE. Potentiation of anticoagulant effect of warfarin by phenylbutazone. N Engl J Med. 1967 Mar 2;276(9):496–501. [PubMed]
Corn, M; Berberich, R. Rapid fluorometric assay for plasma warfarin. Clin Chem. 1967 Feb;13(2):126–131. [PubMed]
Gottfried, S; Parke, DV; Sacra, PJ; Thornton, PC. Proceedings: Interaction of carbenoxolone sodium with other drigs bound to plasma proteins. Br J Pharmacol. 1975 Oct;55(2):252P–253P. [PubMed]
Jun, HW; Luzzi, LA; Hsu, PL. Phenylbutazone-sodium warfarin binding using a fluorescent probe technique. J Pharm Sci. 1972 Nov;61(11):1835–1837. [PubMed]
O'Reilly, RA; Levy, G. Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man. J Pharm Sci. 1970 Sep;59(9):1258–1261. [PubMed]